Pain control methods

Pain is a complex interplay of sensory, emotional and cognitive processes that signals potential or actual tissue damage.

There are four broad categories:

• Nociceptive pain – caused by stimulation of peripheral nociceptors by harmful stimuli, such as a sprained ankle
• Inflammatory pain – triggered when inflammatory mediators sensitise receptors
• Neuropathic pain – linked to lesions or dysfunction in the somatosensory system, often described as burning, shooting or electricity-like sensations
• Nociplastic pain – occurs when there’s altered nociception without clear tissue damage (seen in conditions like fibromyalgia)

Identifying the underlying mechanism helps clinicians target treatment more effectively.

Clinically, pain is also classified by duration and purpose:

• Acute pain – starts suddenly, often after trauma, surgery or illness. It plays a protective role by prompting rest and usually fades within days or weeks once the cause is resolved.
• Chronic pain – lasts beyond normal healing time, often longer than three months. It can become a condition in its own right. Central and peripheral sensitisation contribute to problems such as hyperalgesia (exaggerated responses to pain) and allodynia (pain from normally non-painful stimuli).

Chronic pain is a major public health challenge in the UK. It affects an estimated one in five adults. The cost to the NHS and wider economy is estimated at over £10 billion annually, when healthcare usage, lost workdays and social care needs are included.

Early, precise differentiation between acute and chronic pain pathways enables clinicians to select the right assessment tools and tailor control methods. This helps prevent maladaptive pain processes (changes in the nervous system that cause pain to persist even after the original injury has healed) and optimises long-term recovery.

Why effective pain management matters

Effective pain control directly influences patient outcomes. It supports physical recovery, psychological well-being and overall quality of life.

When pain is not managed, mobility is reduced, sleep is disrupted and stress responses are triggered. Elevated cortisol and catecholamine levels can create extra cardiovascular strain and delay wound healing.

In surgical settings, good pain relief helps patients make progress, which can mean getting back on their feet more quickly. This reduces the risk of complications like deep vein thrombosis, pulmonary dysfunction and muscle loss. When pain is not properly managed, patients may be in hospital for longer. Readmission also becomes more likely.

The effects go beyond the physical. Ongoing pain is closely linked to anxiety, depression and PTSD. These conditions can feed back into pain itself, creating a cycle that’s hard to break.

Chronic pain also places a heavy burden on healthcare systems and the wider economy. It leads to frequent GP visits, specialist referrals and investigations. People experiencing pain may be less productive at work and make disability claims. Structured pain management pathways help reduce these pressures. They improve patient satisfaction, cut avoidable costs and ensure providers meet regulatory standards.

Compassionate pain control is also an ethical duty in healthcare. Respecting patient dignity and autonomy involves acknowledging pain as a fundamental human experience and striving to ease unnecessary suffering. In palliative and end-of-life care, where cure is not the objective, effective pain relief is central to comfort and holistic care.

How is pain measured? Assessment tools

Accurately measuring pain intensity and its wider impact is key to any effective control strategy.

Because pain is subjective, self-report tools remain the gold standard:

• The numeric rating scale (NRS) asks patients to rate their pain from 0 (no pain) to 10 (worst imaginable pain). It’s simple and responsive to change.
• The visual analogue scale (VAS) uses a 10-cm line between “no pain” and “worst imaginable pain”, allowing continuous data capture for research and clinical audits.
• Multidimensional tools provide deeper insights. For example, the McGill Pain Questionnaire assesses sensory, affective and evaluative components, helping tailor treatment.

Not everyone can self-report pain. Behavioural tools are useful for children and patients who are critically ill or have cognitive impairment:

• The Faces Pain Scale – Revised (FPS-R) enables children to indicate pain severity via facial expressions.
• The Pain Assessment in Advanced Dementia (PAINAD) scale interprets breathing patterns, vocalisation, facial expressions and body language.
• Neuropathic pain often warrants specialised instruments like the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS). This method helps distinguish neuropathic pain from nociceptive pain.

Other methods support ongoing monitoring:

• Patient diaries, paper-based or via smartphone apps, track pain episodes, medication use and triggering factors, creating a longitudinal record.
• Wearable sensors can capture objective data, such as heart rate variability and activity levels, to support patient reports.

Integrating these tools within electronic health records supports scheduled reviews – every four hours after surgery, monthly in chronic pain clinics or tailored to individual needs. This ensures treatment stays on track and helps patients feel more engaged in their care.

Overview of pharmacological approaches

Pharmacological strategies form the backbone of many pain management plans. They use medicines that act on nociceptive and central pain pathways.

Historically, analgesics have been organised into a stepped-care or “analgesic ladder” model, which was first developed by the World Health Organization for cancer pain and adapted for broader use.

• Step one – non-opioid medicines such as paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs), used for mild to moderate pain
• Step two – weak opioids or combination preparations, added when non-opioids are not enough
• Step three – strong opioids, reserved for severe pain

Adjuvant medications, including anticonvulsants and certain antidepressants, can be added at any stage to target neuropathic pain or central sensitisation.

The choice of drug depends on the cause and severity of pain, comorbidities and patient preferences.

• Paracetamol – often first-line because it’s generally safe, but careful dose monitoring is needed to avoid liver damage
• NSAIDs – helpful for inflammation, though they can cause gastrointestinal irritation, kidney problems and cardiovascular risks
• Opioids – powerful but require careful prescribing to reduce the risk of tolerance, dependence and side effects
• Adjuvants – options include gabapentinoids, tricyclic antidepressants and topical agents, often used for neuropathic or complex pain

Routes of administration also matter. These include oral, transdermal, intravenous, subcutaneous or regional techniques. Rapid-acting medicines may be chosen for breakthrough pain, while transdermal patches provide steady relief for chronic conditions.

Clinicians must balance effectiveness with safety, continually reassessing as needs change. This may involve titrating doses, rotating drugs or tapering use. Guidance such as NICE NG193 on chronic pain offers evidence-based recommendations to support these decisions.

Over-the-counter and prescription analgesics

Self-care begins with readily available over-the-counter (OTC) options. Paracetamol is a mainstay for mild to moderate pain. OTC NSAIDs – including ibuprofen and naproxen – help with both pain and inflammation, though long-term or high-dose use increases the risk of stomach ulcers, kidney problems and high blood pressure.

When OTC measures are not enough, prescription-only medicines may be needed.

• Stronger NSAIDs – such as diclofenac or celecoxib, prescribed under medical supervision. Proton-pump inhibitors are often given alongside them to reduce the risk of gastrointestinal side effects.
• Weak opioid combinations – such as co-codamol (paracetamol with codeine). These can give extra relief but must be monitored for sedation, constipation and misuse.

Clinicians must advise patients about safe daily limits, possible interactions (for instance, combining NSAIDs with blood pressure medicines) and the need to stick to dosing schedules.

Patient education makes a big difference. Pharmacy guidance and clear written materials help people use medicines safely. A simple medication diary helps track usage patterns, identify emerging side effects and facilitate informed discussions during GP consultations.

For chronic conditions that outlast OTC options, early referral to a GP ensures access to tailored prescriptions and comprehensive review.

Opioid use – benefits, risks and guidelines

Opioids are indispensable for managing moderate to severe pain, particularly in acute, cancer-related and palliative care settings. However, they are high-risk and have strong side effects. A careful, evidence-based approach is needed.

Benefits

By binding to mu-opioid receptors in the central nervous system, opioids like morphine, oxycodone and fentanyl effectively dampen pain transmission and alter pain perception.

In surgical recovery and trauma care, they deliver rapid, intense relief, helping patients mobilise and take part in physiotherapy sooner.

In palliative contexts, the focus shifts to comfort, enabling patients to maintain dignity and participate in daily activities. With careful dosing, they can enhance sleep quality, mood and overall function, reducing the burden of severe pain on patients and their caregivers.

Risks

Opioid therapy comes with well-known risks.

Tolerance can develop quickly, leading to higher doses and more side effects. These include constipation, nausea, drowsiness and, in serious cases, respiratory depression. Dependence and withdrawal symptoms may appear even after short courses, making stopping difficult. Long-term use can cause opioid-induced hyperalgesia – a paradoxical rise in pain sensitivity. There is also the risk of misuse and addiction, which has fuelled major public health challenges worldwide.

Guidelines

National guidance recommends avoiding opioids for non-cancer chronic pain and using the smallest effective dose for the least time.

Safe practice relies on regular reviews – assessing pain relief, functional improvement and adverse events. Safety can be strengthened through:

• Treatment agreements – setting clear expectations between patient and clinician
• Education on safe storage and disposal – to prevent diversion or accidental use
• Naloxone – which quickly reverses opioid effects in emergencies

When a patient needs long-term opioid therapy, multidisciplinary teams – including pain specialists, pharmacists and psychologists – should be involved to provide comprehensive oversight and optimise outcomes.

Non-steroidal anti-inflammatory drugs

NSAIDs relieve pain with an inflammatory component.

• Oral NSAIDs, including ibuprofen, naproxen and diclofenac, are first-line treatments for conditions like osteoarthritis, rheumatoid arthritis and acute soft tissue injuries.
• Topical formulations, like diclofenac gel (e.g., Voltarol) or ibuprofen patches, deliver localised effects with lower systemic risks, making them a good choice for focal musculoskeletal pain.

Despite their usefulness in pain management, doctors should carry out a careful risk–benefit evaluation when prescribing NSAIDs:

• Gastrointestinal risks – ulceration, bleeding and indigestion, particularly in older adults or those also using corticosteroids

• Cardiovascular concerns – raised blood pressure and thrombotic events, requiring caution in patients with ischaemic heart or cerebrovascular disease
• Renal risks – impaired kidney function, especially in older adults or people who are dehydrated

Mitigation strategies include:

• Lowest effective dose – and for the shortest possible time
• Proton-pump inhibitors – co-prescribed to protect the stomach
• Topical preparations – preferred over oral options where suitable

Condition-specific advice on safe and effective NSAID use is available from organisations like Versus Arthritis, which provides tailored advice for people living with arthritis.

Adjuvant medications for neuropathic pain

Neuropathic pain – caused by damage to or dysfunction of the peripheral or central nervous system – often doesn’t respond to traditional analgesics. Adjuvant medications, originally developed for other indications, target abnormal neural signalling and central sensitisation.

• Tricyclic antidepressants (TCAs), particularly amitriptyline, enhance descending inhibitory pathways by blocking serotonin and noradrenaline reuptake. Their efficacy in conditions like diabetic neuropathy and post-herpetic neuralgia is well-established. Because of their anticholinergic side effects and risk of heart problems, TCAs should be prescribed with care, and older adults may need ECG monitoring.
• Serotonin–noradrenaline reuptake inhibitors (SNRIs) like duloxetine offer similar benefits to TCAs but with more tolerable side effects.
• Anticonvulsants like gabapentin and pregabalin work by modulating calcium channels to calm overactive nerve activity. Starting at low doses and increasing gradually helps limit side effects like dizziness, somnolence and peripheral oedema.
• Topical agents, such as lidocaine patches and capsaicin cream, deliver local pain relief with minimal systemic absorption. They are especially useful for localised neuropathic pain, such as post-surgical nerve pain or small areas of neuralgia.

Adjuvant medicines need to be part of a broader treatment plan. Regular reviews and dose adjustments are essential to balance pain relief, function and side effects. National guidance supports introducing these drugs early when neuropathic pain is suspected, rather than relying on steadily increasing opioid doses.

Physical therapies for pain

Physical approaches are an important part of managing both acute and chronic pain.

• Heat therapy – applying warmth increases local blood flow, relaxes muscles and makes tissues more flexible. It’s valuable for chronic musculoskeletal stiffness and subacute injuries. Approaches include using hot water bottles or electric heating pads and hydrotherapy. Sessions typically last for 20–30 minutes before stretching or exercise to improve flexibility.

• Cold therapy – this approach lowers blood flow and slows the metabolic processes in tissues, which helps reduce swelling and pain. It is most effective for sudden injuries like sprains or strains. Ice packs or cold compresses are generally used for no longer than 15–20 minutes at a time to avoid skin or tissue damage.
• Massage therapy – techniques such as gentle strokes, kneading or myofascial release can improve circulation, ease tightness and reduce pain. Regular massage may help with problems like back pain, tension headaches or fibromyalgia. It also supports relaxation.
• Exercise programmes – tailored plans that include aerobic activity, strength work and stretching help build muscle support, improve joint stability and activate the body’s own pain control systems. Programmes usually start gently, for example with walking or pool exercises, and progress gradually to suit each person’s ability and goals.

Physiotherapy and occupational therapy support

Physiotherapists and occupational therapists deliver specialised assessments and interventions that address the physical and functional aspects of pain.

• Physiotherapy – techniques may include manual therapy such as joint mobilisation or soft-tissue massage, as well as electrotherapies like transcutaneous electrical nerve stimulation (TENS), which uses gentle electrical currents to disrupt pain signals. Tailored exercise programmes focus on rebuilding strength, endurance and balance, with gradual progressions to avoid flare-ups.
• Occupational therapy – therapists look at how pain affects daily routines and recommend adjustments to make life easier. This might involve workstation assessments, assistive devices for self-care or energy-saving strategies to combat fatigue. Splints and joint protection techniques support people with conditions such as rheumatoid arthritis, while vocational rehabilitation helps with planning a safe return to work.

In primary care, referral pathways connect patients to community-based therapy services. Complex cases often benefit from integrated rehabilitation programmes, where therapists collaborate with pain specialists, psychologists and social workers to create holistic management plans.

Guidance from professional bodies, such as the Chartered Society of Physiotherapy, helps ensure practice is evidence-based and up to date.

Psychological pain management methods

Psychological approaches to pain management recognise that thoughts, emotions and behaviours significantly influence how people perceive pain and cope with it.

• Cognitive behavioural therapy (CBT) – CBT helps people identify and challenge unhelpful thoughts – such as catastrophising – and replace them with healthier coping strategies. Structured sessions cover goal-setting, activity pacing and problem-solving, reducing pain intensity and improving day-to-day function in chronic conditions.
• Mindfulness – mindfulness-based interventions encourage awareness and acceptance. Techniques like mindful breathing, body scans and meditation can change the way the brain processes pain, helping people respond with less distress and more resilience.
• Relaxation techniques – techniques like progressive muscle relaxation, guided imagery and diaphragmatic breathing aim to activate the parasympathetic nervous system. This can decrease muscle tension and ease any pain that is amplified by stress. Regular practice equips people to handle flare-ups when they arise.

Access to trained professionals and accredited programmes, supported by organisations like Mind and the British Psychological Society, ensures these therapies are delivered safely and effectively.

Complementary therapies

Complementary therapies can support conventional treatments by offering alternative pain relief pathways and enhancing well-being.

• Acupuncture – this traditional Chinese practice uses fine needles at specific meridian points to restore energy balance and stimulate the body’s own pain-relieving mechanisms. Clinical reviews demonstrate modest benefits for chronic low back pain, osteoarthritis and migraines. In the UK, national guidance supports acupuncture as an add-on treatment when standard options alone are not effective.
• Aromatherapy – essential oils like lavender, chamomile and peppermint promote relaxation and ease discomfort. When blended with carrier oils during massage, they combine the benefits of touch with possible anti-inflammatory and calming effects. While research findings vary, some studies show improvements in pain and anxiety when aromatherapy is part of wider care.

Practitioners should always follow safety standards – using diluted oils, patch testing for sensitivity and checking for any interactions with existing treatments. Effective collaboration between complementary therapists and medical teams helps keep strategies coherent and patient-centred.

Pain management in palliative and end-of-life care

In palliative and end-of-life settings, the primary aim is to maximise comfort and dignity. Pain control is tailored to the patient’s wishes and clinical goals.

The WHO analgesic ladder provides a framework for pain control. It starts with non-opioids and progresses to strong opioids, with adjuvant drugs added for pain linked to nerves or bones.

Care is not only about medication. Holistic assessment looks at the physical, psychological, social and spiritual aspects of pain – often described as “total pain” – to make sure every dimension is addressed.

When medicines alone are not enough, interventional approaches can help. Options such as peripheral nerve blocks, epidural or intrathecal infusions and neurolytic procedures provide targeted relief.

Combining oral, parenteral and transdermal routes gives consistent relief and flexibility with dosing. Advance care planning also plays a key role, creating space to discuss sedation, protocols for breakthrough pain and the overall goals of care with patients and their families.

Community palliative teams and hospice services deliver multidisciplinary support, often at home, reducing hospital admissions and allowing patients to be cared for in familiar surroundings. Education for family members or friends providing care covers:

• Safe administration of “as required” (PRN) medications
• How to recognise uncontrolled pain
• When to seek professional advice

Practical guidance and psychosocial support are also available via resources like theCancer Research UK palliative care guide.

Tailoring pain control to age, condition and setting

Everyone experiences pain differently, and treatment needs to reflect that.

• Children need age-appropriate tools, such as pictorial scales, and medicines in liquid suspensions or dispersible tablets for accurate dosing.
• Older adults often have several health conditions and take multiple medicines. They require cautious dose adjustments and regular checks for kidney and liver function.
• Pain in pregnant women is usually managed with paracetamol, with specialist oversight for any additional drugs to protect both mother and baby.
• People with chronic conditions such as cardiovascular disease, psychiatric illness or substance misuse need personalised plans that avoid drug interactions and do not worsen existing problems.

The care setting itself also shapes how pain is managed:

• Inpatient settings may use intravenous infusions or patient-controlled analgesia (PCA) devices to deliver steady and effective pain relief.
• Rural or resource-limited environments benefit from telehealth, remote monitoring and community pain teams to ensure continuity of care.

Patient education and self-management

Empowering patients to take an active role in pain management is key to long-term success. They should be guided on the nature of pain, realistic expectations for relief and safe medication use – including how to recognise side effects and signs of drug interactions. Written materials, online modules and smartphone apps reinforce learning, while structured self-management programmes help build skills.

• Pain diaries allow people to track intensity, triggers and responses to treatment, giving clinicians valuable information for tailoring care.
• Goal-setting focuses on functional objectives, such as gradually increasing walking distance, and helps reduce avoidance behaviours.
• Peer support through groups and mentoring schemes builds motivation, encourages shared learning and reduces isolation.
• Digital platforms endorsed by the NHS – offering guided exercises, relaxation audios and medication reminders – help bridge gaps between clinic visits and encourage consistency.

Monitoring effectiveness and adjusting treatment

Pain control requires ongoing review and adaptation to stay effective and safe. Structured monitoring frameworks assess:

• Intensity – using standard scales at defined intervals
• Function – measuring improvements in mobility, sleep and daily activities
• Side effects – tracking adverse events such as gastrointestinal discomfort or sedation
• Psychosocial impact – evaluating mood, anxiety and quality-of-life metrics

Objective measures – range-of-motion tests, activity trackers or sleep monitors – provide a holistic perspective. Formal reviews occur daily in acute care, weekly during dose titration and monthly in stable chronic regimens, with flexibility to review sooner if breakthrough pain arises.

Titration strategies include:

• Increasing the dose
• Rotating opioids to reduce tolerance
• Introducing adjuvants if pain changes in character

Deprescribing protocols support the safe withdrawal of drugs that are no longer effective or well-tolerated. They aim to reduce the risk of withdrawal effects.

Clear records in electronic health systems keep everyone on the same page, helping teams communicate, track progress and maintain patient safety.

Multidisciplinary pain clinics and services

When pain remains complex and doesn’t respond to standard treatment, referral to a multidisciplinary pain clinic can make a difference, as it offers integrated expertise. These clinics bring together pain medicine specialists, nurses, physiotherapists, occupational therapists, psychologists and pharmacists to provide joined-up care. Assessments cover physical health, daily function and emotional well-being, allowing for a tailored plan based on the person’s needs.

Interventional procedures – epidural steroid injections, nerve blocks, spinal cord stimulators – may be offered alongside medication and rehabilitation. Meanwhile, group education sessions, pain self-management workshops and peer support networks give people extra tools and help them feel less isolated.

Referral criteria usually follow local pain pathways, with GPs or hospital specialists making the initial request. To support access, The British Pain Society maintains a directory of regional services.